Steven C. Quay

Insider Reports History

Location
22026 20 Th Avenue S E, Suite 102, Bothell, WA
Signature
/s/ Steven C. Quay
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Steven C. Quay:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ATOSSA THERAPEUTICS, INC. President & CEO, Director Common Stock 22.3K $17.8K $0.80 May 21, 2025 By Ensisheim Partners, LLC
ATOSSA THERAPEUTICS, INC. President & CEO, Director Common Stock 13.9K $12.2K $0.88 May 21, 2025 Direct
ATOSSA THERAPEUTICS, INC. President & CEO, Director Stock Option (right to buy) 1.37M May 15, 2025 Direct

Insider Reports Filed by Steven C. Quay

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ATOS ATOSSA THERAPEUTICS, INC. May 21, 2025 1 $9.89K 4 May 22, 2025 President & CEO, Director
ATOS ATOSSA THERAPEUTICS, INC. May 15, 2025 1 $0 4 May 16, 2025 President & CEO, Director
ATOS ATOSSA THERAPEUTICS, INC. Jun 27, 2024 1 $0 4 Jul 1, 2024 President & CEO, Director
ATOS ATOSSA THERAPEUTICS, INC. Mar 2, 2023 1 $0 4 Mar 6, 2023 President & CEO, Director
ATOS ATOSSA THERAPEUTICS, INC. Feb 24, 2022 1 $0 4 Feb 28, 2022 President & CEO, Director
ATOS ATOSSA THERAPEUTICS, INC. May 14, 2021 1 $0 4 May 18, 2021 President & CEO, Director
ATOS ATOSSA THERAPEUTICS, INC. May 14, 2021 1 $0 4 May 18, 2021 President & CEO, Director